Literature DB >> 8234417

Pharmacokinetic-metabolic studies with 14C-aloe emodin after oral administration to male and female rats.

W Lang1.   

Abstract

After oral administration of 4.5 mg/kg 14C-aloe emodin (AE) to rats 20-30% of the dose was excreted in urine and the rest in feces. AE was quickly metabolized to rhein, to an unknown metabolite and to conjugates of all three. In the plasma about 10% of 14C-activity was identified as free AE. Maximum plasma values were reached 1.5-3 h p.a. with 248 (male) and 441 (female) ng equivalents AE/ml. Maximum concentrations in plasma were about 3 times higher than those in ovaries and 10 times higher than those in testes. Only liver, kidney and intestinal tract showed higher concentrations than plasma. Terminal half-life (for radioactivity) in blood was about 50 h.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234417     DOI: 10.1159/000139849

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  4 in total

Review 1.  The dark side of miracle plant-Aloe vera: a review.

Authors:  Alka Jangra; Garima Sharma; Sonia Sihag; Vinod Chhokar
Journal:  Mol Biol Rep       Date:  2022-01-29       Impact factor: 2.742

Review 2.  Pharmacokinetics of Anthraquinones from Medicinal Plants.

Authors:  Dongpeng Wang; Xian-He Wang; Xiongjie Yu; Fengjun Cao; Xiaojun Cai; Ping Chen; Minglun Li; Yibin Feng; Hongliang Li; Xuanbin Wang
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

3.  Pharmacokinetics, Tissue Distribution, and Excretion Characteristics of a Radix Polygoni Multiflori Extract in Rats.

Authors:  Wenhao Cheng; Siyang Wu; Zheng Yuan; Weiyu Hu; Xin Yu; Nianxin Kang; Qiutao Wang; Mingying Zhu; Kexin Xia; Wei Yang; Chen Kang; Shuofeng Zhang; Yingfei Li
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

4.  Metabolism and pharmacokinetics of san-huang-xie-xin-tang, a polyphenol-rich chinese medicine formula, in rats and ex-vivo antioxidant activity.

Authors:  Chi-Sheng Shia; Yu-Chi Hou; Shin-Hun Juang; Shang-Yuan Tsai; Pei-Hsun Hsieh; Lu-Ching Ho; Pei-Dawn Lee Chao
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-07       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.